501
Views
57
CrossRef citations to date
0
Altmetric
Original Research

Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness

, &
Pages 277-283 | Published online: 29 Apr 2019

References

  • The American Society of Plastic Surgeons. Plastic Surgery StatisticsReport. Available from: https://www.plasticsurgery.org/news/press-releases/new-statistics-reveal-theshape-of-plastic-surgery. Accessed 31, 2017.
  • The American Society for Dermatologic Surgery. ASDS Survey. Available from: https://www.asds.net/_Media.aspx?id=9449, https://www.asds.net/. Accessed May 17, 2018.
  • Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg. 2005;31(11 Pt 2):1616–1625.16416647
  • De Boulle K. Management of complications after implantations of fillers. J Cosmet Dermatol. 2004;3(1):2–15. doi:10.1111/j.1473-2130.2004.00058.x17163941
  • Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol. 2007;6:167–171. doi:10.1111/j.1473-2165.2007.00331.x17760694
  • Rongioletti F. Complications granulomateuses des techniques de comblement. Ann Dermatol Venereol. 2008;135:59–65. doi:10.1016/S0151-9638(08)70213-8
  • Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg. 2015;41:929–939. doi:10.1097/DSS.000000000000041826166260
  • André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18:422–425.15196154
  • Lee JM, Kim YJ. Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg. 2015;42:232–239. doi:10.5999/aps.2015.42.5.59625798398
  • De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015;15(8):205–214. doi:10.2147/CCID.S80446
  • Moscona RR, Bergman R, Friedman-Birnbaum R. An unusual late reaction to Zyderm I injections: A challenge for treatment. Plast Reconstr Surg. 1993;92:331. doi:10.1097/00006534-199308000-000218068054
  • Williams CT, Williams WJ. Granulomatous inflammation: a review. J Clin Pathol. 1983;36:723.6345591
  • Alijotas-Reig J, Fernández-Figueras MT, Puig L. Late-onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol. 2013;45:97–108. doi:10.1007/s12016-012-8348-523361999
  • Bitterman-Deutsch O, Kogan L, Nasser F Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literature. Dermatol Report. 2015;7:5851. doi:10.4081/dr.2015.5851
  • Cyphert JM, Trempus CS, Garantziotis S. Size matters: molecular weight specificity of Hyaluronan effects in cell biology. Int J Cell Biol. 2015;2015:563818. doi:10.1155/2015/56381826448754
  • Gonzalez-Delgado P, Blanes M, Soriano V, Montoro D, Loeda C, Niveiro E. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol Immunopathol. 2006;34:76–78. doi:10.1157/13086752
  • Onodi-Nagy K, Kinyo A, Meszes A, et al. Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization. Allergy Asthma Clin Immunol. 2015;11:1. doi:10.1186/s13223-015-0099-425784943
  • Jordan AR, Racine RR, Hennig MJ, Lokeshwar VB. The role of CD44 in disease pathophysiology and targeted treatment. Front Immunol. 2015;6:182. doi:10.3389/fimmu.2015.0018225954275
  • Wagner RD, Fakhro A, Cox JA, Izaddoost SA. Etiology, prevention, and management of infectious complications of dermal fillers. Semin Plast Surg. 2016;30:83–86. doi:10.1055/s-0036-158073427152101
  • Tseng CHW, Chen AM, Chang JYF. Hyaluronic acid injectioninduced delayed-onset foreign body granuloma. J Dental Sci. 2015;10:341–343. doi:10.1016/j.jds.2015.03.008
  • Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Plast Surg Nurs. 2015;35:13–32. doi:10.1097/PSN.000000000000008725730536
  • Signorini M, Liew S, Sundaram H, et al.; Global Aesthetics Consensus Group. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016;137:961e–971e. doi:10.1097/PRS.0000000000002184
  • Alijotas-Reig J, Fernández-Figueras MT, Puig L. Pseudocystic encapsulation: a late noninflammatory complication of hyaluronic acid filler injections. Dermatol Surg. 2013;39:1726–1728. doi:10.1111/dsu.1231624112418
  • Homsy A, Rüegg EM, Jandus P, Pittet-Cuénod B, Modarressi A. Immunoligical reaction after facial hyaluronic acid injection. Case Reports Plast Surg Hand Surg. 2017;4(1):68–72.
  • Bhojani-Lynch T. Late-onset inflammatory response to hyal-uronic acid fillers. Dermal Plast Reconstruc Surg. 2017;5(12):e1532.
  • Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Derm. 1996;35:234–236. doi:10.1111/j.1600-0536.1996.tb02364.x8957644
  • Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001;107:1433–1441. doi:10.1172/JCI1050111390425
  • Padial MA, Alvarez-Ferreira J, Tapia B, et al. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol. 2004;150:139. doi:10.1111/j.1365-2133.2004.05717.x14746629